Wedge Capital Management L L P NC bought a new position in Prestige Consumer Healthcare Inc (NYSE:PBH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 218,072 shares of the company’s stock, valued at approximately $8,832,000. Wedge Capital Management L L P NC owned approximately 0.43% of Prestige Consumer Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently added to or reduced their stakes in PBH. Oppenheimer Asset Management Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 113.6% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 771 shares of the company’s stock valued at $27,000 after buying an additional 410 shares in the last quarter. Bridger Capital Management LLC bought a new position in shares of Prestige Consumer Healthcare during the 3rd quarter worth approximately $52,000. Tower Research Capital LLC TRC lifted its position in Prestige Consumer Healthcare by 100.6% during the third quarter. Tower Research Capital LLC TRC now owns 1,657 shares of the company’s stock valued at $57,000 after acquiring an additional 831 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Prestige Consumer Healthcare during the third quarter valued at approximately $108,000. Finally, Robeco Institutional Asset Management B.V. acquired a new stake in Prestige Consumer Healthcare in the third quarter valued at approximately $150,000.
In other news, insider Paton Brett 586,594 shares of the company’s stock in a transaction dated Monday, November 11th. 1.14% of the stock is owned by insiders.
PBH opened at $40.56 on Friday. The company has a market cap of $2.11 billion, a P/E ratio of -62.40, a price-to-earnings-growth ratio of 2.29 and a beta of 0.93. Prestige Consumer Healthcare Inc has a 52-week low of $26.49 and a 52-week high of $42.73. The company has a quick ratio of 1.22, a current ratio of 2.08 and a debt-to-equity ratio of 1.60. The firm’s 50-day moving average price is $40.44 and its 200-day moving average price is $36.23.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, October 31st. The company reported $0.68 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.02. The business had revenue of $238.07 million for the quarter, compared to analyst estimates of $237.17 million. Prestige Consumer Healthcare had a negative net margin of 3.56% and a positive return on equity of 12.68%. Prestige Consumer Healthcare’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.65 EPS. On average, research analysts anticipate that Prestige Consumer Healthcare Inc will post 2.82 EPS for the…